Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
neomycin sulfate + polymyxin b sulfate + hydrocortisone is a combination pharmaceutical product for topical use, most commonly as otic drops, containing **two antibiotics** (neomycin sulfate, polymyxin b sulfate) and **one corticosteroid** (hydrocortisone)[1][2][6]. - **Neomycin sulfate** is an aminoglycoside antibiotic, **polymyxin b sulfate** is a polypeptide antibiotic—both work by inhibiting bacterial protein synthesis (neomycin) and disrupting bacterial cell membranes (polymyxin B), respectively[2][6]. - **Hydrocortisone** is a synthetic corticosteroid that reduces inflammation, swelling, redness, and itching[1][2][6]. The **primary indication** is superficial bacterial infections of the external auditory canal (outer ear infections), including those that may occur after ear surgeries such as mastoidectomy[1][2][6]. This combination is not appropriate for all bacterial infections due to possible resistance, and should not be used if there is a hole or tear in the eardrum[6]. **Formulated as** both a solution and a suspension for otic use (ear drops), each mL typically contains: neomycin sulfate (equivalent to 3.5 mg neomycin base), polymyxin b sulfate (equivalent to 10,000 polymyxin b units), and hydrocortisone (10 mg/1%)[3][6]. **Prescribed only** under medical supervision and for short-term use[1][6]. **Common side effects** include local irritation and, rarely, allergic reactions such as rash, swelling, or hearing loss (ototoxicity)[6]. **Not recommended** for viral, fungal, or mycobacterial infections, or if there is known hypersensitivity to any component[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on neomycin sulfate + polymyxin b sulfate + hydrocortisone.